Core Viewpoint - Yangnong Chemical achieved a net profit attributable to shareholders of 1.055 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 2.88% [1] Financial Performance - In Q3 2025, the net profit attributable to shareholders was 250 million yuan, showing a year-on-year decrease of 5.01% and a quarter-on-quarter decrease of 32.72% [1] Business Development - The company is advancing the construction of dual bases in both northern and southern regions [1] - The raw material business continues to grow, with price increases in certain pesticide products [1] Project Updates - The Huludao base's first phase, with an annual production capacity of 15,700 tons of raw materials and 7,000 tons of intermediates, officially commenced construction in June 2023, with production expected to start in December 2025 [1] - The first phase has begun trial production as of July 2024, with all products meeting design capacity [1] - The second phase of the first phase is scheduled for equipment and electrical installation completion by June 2025 [1] Product Coverage - Upon full production, the facility will cover the entire chain of insecticides, fungicides, herbicides, and plant growth regulators [1] Capacity Expansion - Subsidiary Jiangsu Youjia is advancing a project to expand production of 3,000 tons of Pyrazole and 22,665 tons of by-products, which will further enhance the company's capacity advantages upon full production [1] Investment Rating - The company maintains a "Buy" rating [1]

Core Viewpoint - Jiangsu TuoQiu Agricultural Chemical Co., Ltd. (hereinafter referred to as "TuoQiu") has initiated IPO counseling with the intention to list on the Beijing Stock Exchange, with Pacific Securities as the counseling institution [2]. Company Overview - TuoQiu was established in April 2003 with a registered capital of approximately 190 million yuan [2][3]. - The company is primarily engaged in the production and sales of pesticide raw materials and formulations, pesticide intermediates, and pharmaceutical intermediates, with leading products including Bromopropylate, Fipronil, Multi-effect Su, and Pyrazole [2]. Shareholding Structure - The actual controller, Liao Dazhang, directly holds 33.72% of TuoQiu's shares and indirectly holds an additional 27.19% through two investment companies, totaling 60.91% [3][4]. - Liao Dazhang's family members also hold shares, with his brother Liao Daqian holding 8.71% and his spouse Zhou Wenlan holding 5.91% [5][6]. Financial Performance - For the first half of 2025, TuoQiu reported operating revenue of approximately 498.13 million yuan, a decrease of 2.81% year-on-year [7]. - The net profit attributable to shareholders increased significantly by 300.73% to approximately 33.69 million yuan [7]. - The gross profit margin improved to 15.44%, up from 9.56% in the previous year [7]. Product Performance - The revenue from insecticides increased by 48.01% year-on-year, driven by higher sales volumes of Fipronil series products, although costs also rose by 45.21% [8].

Core Viewpoint - Jiangsu TuoQiu Agricultural Chemical Co., Ltd. (referred to as "TuoQiu Co.") has initiated IPO counseling with the Jiangsu Securities Regulatory Bureau, aiming for a listing on the Beijing Stock Exchange, with Pacific Securities as the counseling institution [2]. Company Overview - TuoQiu Co. was established in April 2003 with a registered capital of approximately 190 million yuan [2][3]. - The legal representative of the company is Liao Dazhang [2]. - The company primarily engages in the production and sales of pesticide raw materials and formulations, pesticide intermediates, and pharmaceutical intermediates, with leading products including Bromopropylate, Fipronil, Multi-effect Su, and Pyrazole Ether Fungicide [2]. Shareholding Structure - Liao Dazhang directly holds 33.72% of TuoQiu Co.'s shares and indirectly holds an additional 27.19% through two investment companies, making the total shareholding 60.91% [3]. Financial Performance - In the first half of 2025, TuoQiu Co. reported an operating income of 498.13 million yuan, a decrease of 2.81% year-on-year [5]. - The net profit attributable to shareholders of the company was 33.69 million yuan, reflecting a significant increase of 300.73% compared to the previous year [5]. - The basic earnings per share rose to 0.18 yuan, marking a 350% increase year-on-year [5].

Core Insights - The company reported a total revenue of 9.156 billion yuan for the first three quarters of 2025, representing a year-on-year increase of 14.23% [1] - The net profit attributable to shareholders for the same period was 1.055 billion yuan, up 2.88% year-on-year, while the net profit excluding non-recurring items was 1.044 billion yuan, an increase of 5.76% year-on-year [1] - In Q3 2025, the company achieved a revenue of 2.923 billion yuan, a year-on-year increase of 26.15%, but the net profit attributable to shareholders decreased by 5.01% to 250 million yuan [1] Revenue and Profit Analysis - The average selling price of raw materials was 62,700 yuan/ton, down 1.12% year-on-year, with sales volume reaching 86,300 tons, an increase of 13.5% year-on-year [2] - The average selling price of formulations was 39,800 yuan/ton, down 1.61% year-on-year, with sales volume of 33,200 tons, a decrease of 3.1% year-on-year [2] - Despite the increase in sales volume, the company's net profit showed only a slight increase due to price declines [2] Product Performance - Key products such as bifenthrin, chlorpyrifos, and glyphosate showed varying price changes, with bifenthrin's market price decreasing by 5.4% and chlorpyrifos increasing by 22.6% [2] - The company is positioned as a leading player in the pesticide industry, particularly in the pyrethroid category, which is expected to benefit from a recovering global crop protection market [2] Project Development - The Youchuang project is progressing steadily, with the first phase of production capacity ramping up and achieving design capacity [3] - This project is included in China Sinochem's "14th Five-Year Plan" and is expected to generate annual revenue of 1.5 billion yuan and net profit of 100 million yuan by 2026, with projections of 4 billion yuan in revenue and 500 million yuan in net profit by 2030 [3] - The advancement of the Youchuang project is anticipated to alleviate bottlenecks faced by the subsidiary Shenyang Kexin and optimize the company's production layout, enhancing its leading position in the market [3] Future Outlook - The pesticide industry is gradually recovering, with some product prices showing signs of improvement, which is favorable for the company as a leading player [3] - The company is projected to achieve net profits of 1.34 billion yuan, 1.53 billion yuan, and 1.74 billion yuan for the years 2025 to 2027, with respective year-on-year growth rates of 11.62%, 13.62%, and 13.86% [3]

Investment Rating - The report maintains a "Buy" rating for Yangnong Chemical (600486) [2] Core Views - The Q3 performance of Yangnong Chemical is in line with expectations, with the Huludao project gradually entering the release phase, indicating a new growth cycle for the company as the industry recovers [1][7] - The agricultural chemical industry is expected to continue its recovery, with the company’s Huludao project progressing steadily, marking the beginning of a new growth phase [7] Financial Data and Earnings Forecast - For Q3 2025, the company achieved total revenue of 9.156 billion yuan, a year-on-year increase of 14% [7] - The net profit attributable to the parent company for Q3 2025 was 1.055 billion yuan, reflecting a year-on-year increase of 3% [7] - The company’s total revenue forecast for 2025 is 11.951 billion yuan, with a projected net profit of 1.304 billion yuan, representing a year-on-year growth of 8.5% [6][8] - The gross profit margin for Q3 2025 was 19.61%, with a net profit margin of 8.54% [7] - The company plans to invest 4.238 billion yuan in the Huludao project, which aims to produce 15,650 tons of pesticide active ingredients and 7,000 tons of pesticide intermediates annually [7] Market Comparison - The closing price of Yangnong Chemical on October 29, 2025, was 68.11 yuan, with a market capitalization of 27.516 billion yuan [2] - The stock has a price-to-book ratio of 2.4 and a dividend yield of 1.35% [2]

Core Viewpoint - The company reported Q3 results that met expectations, but the prices of most main products remain under pressure. The outlook for the Liaoning Youchuang project is positive as it ramps up production [1] Financial Performance - For the first three quarters of 2025, the company achieved revenue of 9.156 billion yuan, a year-on-year increase of 14.2%, and a net profit attributable to shareholders of 1.055 billion yuan, up 2.9% year-on-year [1] - In Q3 alone, revenue was 2.923 billion yuan, reflecting a year-on-year increase of 26.1% but a quarter-on-quarter decrease of 2.3%. The net profit attributable to shareholders was 250 million yuan, down 5% year-on-year and down 32.7% quarter-on-quarter [1] - The company adjusted its profit forecasts for 2025, expecting net profits of 1.265 billion yuan (down 1.45 billion), 1.6 billion yuan, and 1.823 billion yuan for 2026-2027, with corresponding EPS of 3.12, 3.95, and 4.50 yuan per share [1] Product Pricing and Sales - In the first nine months of 2025, the company sold 86,300 tons of raw materials and 33,200 tons of formulations, with year-on-year changes of +13.5% and -3.1% respectively. Revenue from raw materials was 5.409 billion yuan (up 12.2%), while formulations generated 1.323 billion yuan (down 4.6%) [2] - The average selling price for raw materials was 62,700 yuan/ton, down 1.1% year-on-year, while formulations averaged 39,800 yuan/ton, down 1.6% year-on-year [2] Profitability - The company's gross profit margin and net profit margin for the first three quarters of 2025 were 22.35% and 11.53%, down 1.67 and 1.27 percentage points year-on-year [2] - In Q3, the gross profit margin was 19.61%, and the net profit margin was 8.54%, reflecting a quarter-on-quarter decline of 2.94 and 3.86 percentage points [2] Market Conditions - As of October 26, the raw material price index reported 74.92 points, up 1.12% year-on-year, with 70% of tracked products showing a year-on-year price decline [2] - The company is experiencing a supply-demand imbalance in most pesticide products, with prices remaining at low levels. However, it is expected to maintain stable operational performance through cost reduction and efficiency improvements [2]

Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company's Q3 performance met expectations, with a revenue of 9.156 billion yuan, up 14.2% year-on-year, and a net profit of 1.055 billion yuan, up 2.9% year-on-year. However, Q3 net profit decreased by 5% year-on-year and 32.7% quarter-on-quarter due to price pressures on main products. The report anticipates a strong medium to long-term growth potential driven by the orderly advancement of the Liaoning Youchuang project [4][5] Financial Summary - For the first three quarters of 2025, the company achieved a revenue of 91.56 billion yuan, with a year-on-year growth of 14.2%. The net profit attributable to the parent company was 10.55 billion yuan, reflecting a year-on-year increase of 2.9% [4] - The company’s revenue for Q3 was 29.23 billion yuan, showing a year-on-year increase of 26.1% but a quarter-on-quarter decrease of 2.3% [4] - The projected net profit for 2025-2027 is 12.65 billion yuan, 16.00 billion yuan, and 18.23 billion yuan respectively, with corresponding EPS of 3.12 yuan, 3.95 yuan, and 4.50 yuan [4][7] Business Performance - In the first nine months of 2025, the company sold 86,300 tons of raw materials, up 13.5% year-on-year, while the sales volume of formulations decreased by 3.1% year-on-year. The average selling price for raw materials was 62,700 yuan per ton, down 1.1% year-on-year [5][10] - The gross profit margin for the first three quarters of 2025 was 22.35%, down 1.67 percentage points year-on-year, while the net profit margin was 11.53%, down 1.27 percentage points year-on-year [5][17] Price Trends - The average selling prices of the company's main products have shown mixed trends, with a significant number of products experiencing price declines. The report notes that 70% of tracked products saw price drops year-on-year, while 69% remained stable month-on-month [5][11] Future Outlook - The report expresses confidence in the company's ability to enhance quality and efficiency, particularly with the ongoing development of the Liaoning Youchuang project, which is expected to contribute positively to growth in the medium to long term [4][5]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 20.90 CNY based on a projected EPS of 0.95, 1.35, and 1.79 CNY for 2025-2027 [4][7]. Core Views - The company experienced a year-on-year revenue growth of 6.84% in Q2, driven by a 9.20% increase in pesticide sales, despite a 1.26% decline in average product prices [10]. - The company's gross profit margin for Q2 was 23.79%, remaining stable year-on-year, while net profit increased by 35.24% to 0.97 billion CNY due to reduced asset impairment losses [10]. - The Hengning base is expected to continue reducing losses as its operational efficiency improves, potentially contributing positively in the future [10]. Financial Summary - Revenue for 2023 is projected at 4,398 million CNY, with a decline of 3.0% year-on-year, followed by a forecasted increase of 23.6% in 2025 [6]. - Operating profit is expected to drop to 242 million CNY in 2024, a decrease of 57.5%, before recovering to 378 million CNY in 2025 [6]. - The net profit attributable to the parent company is forecasted to be 473 million CNY in 2023, with a significant drop of 61.7% in 2024, followed by a recovery to 324 million CNY in 2025 [6]. - The company’s gross margin is expected to decline to 23.9% in 2024, before gradually improving to 25.7% by 2027 [6].

Core Viewpoint - The company's second-quarter performance showed a year-on-year increase driven by sales growth and a reduction in impairment losses, despite a generally low industry sentiment and price pressures on key products [1][2]. Group 1: Sales and Financial Performance - The company's pesticide business saw a 9.20% year-on-year increase in sales volume in the second quarter, leading to a revenue of 1.345 billion, which is a 6.84% increase year-on-year [1]. - The average price of the company's pesticide products decreased by 1.26% year-on-year in the second quarter, indicating stabilization after a period of decline [1]. - The net profit attributable to the parent company reached 97 million in the second quarter, reflecting a year-on-year growth of 35.24%, primarily due to reduced asset impairment losses [1]. Group 2: Operational Developments - The Hengning subsidiary, a key growth driver for the company, has seen an increase in operational efficiency, with total assets reaching nearly 2 billion [1]. - The Hengning project has faced challenges since its initial production in June 2022, resulting in losses of 141 million and 163 million for 2023 and 2024, respectively, attributed to high initial investment and low utilization rates [2]. - Improvements in the Hengning project are expected as production capacity utilization increases, leading to a reduction in losses and potential positive contributions in the future [2]. Group 3: Profit Forecast and Investment Recommendations - Due to the declining prices of key products in the pesticide industry, the company's earnings per share (EPS) forecasts for 2025-2027 have been adjusted to 0.95, 1.35, and 1.79, down from previous estimates [3]. - The target price is set at 20.90, based on a 22 times price-to-earnings ratio for comparable companies, while maintaining a buy rating [3].

Group 1: Financial Performance - In the first half of 2025, the company achieved revenue of 6.234 billion yuan, a year-on-year increase of 9.38% [1] - The net profit attributable to shareholders was 806 million yuan, up 5.60% year-on-year, while the net profit excluding non-recurring items was 796 million yuan, increasing by 7.86% [1] - In Q2 2025, the company reported revenue of 2.993 billion yuan, a year-on-year growth of 18.63% but a quarter-on-quarter decline of 7.64% [1] Group 2: Product Pricing and Sales - The average selling prices for raw materials and formulations in H1 2025 were 64,500 yuan/ton and 41,600 yuan/ton, down 3.04% and 2.89% year-on-year, respectively [2] - Sales volumes for raw materials and formulations were 56,700 tons and 28,100 tons, reflecting increases of 13.43% and 0.12% year-on-year [2] - The market prices for key products in Q2 2025 showed mixed trends, with glyphosate at 23,400 yuan/ton (down 8.72% year-on-year) and other products experiencing various percentage changes [2] Group 3: Industry Trends - The agricultural chemical industry is showing signs of stabilization, with a 10% year-on-year increase in pesticide production in China during the first half of 2025 [3] - China's pesticide exports reached 1.806 million tons in H1 2025, a year-on-year increase of 15.72%, with export value rising to 4.902 billion USD, up 13.38% [3] - The market prices for major products as of August 23, 2025, showed varying changes compared to the beginning of the year, with glyphosate increasing by 13.95% [3] Group 4: Project Developments - The Huludao project is progressing rapidly, focusing on the production of insecticides, fungicides, herbicides, and related intermediates, with an annual capacity of 15,650 tons of pesticide raw materials [4] - The first phase of the project has been fully operational, while the second phase began trial production in July 2025 [4] - A subsidiary is expected to commence production of 3,000 tons of pyrazole ester and 22,665 tons of by-products in Q3 2025 [4] Group 5: Investment Outlook - The company forecasts net profits attributable to shareholders of 1.412 billion, 1.665 billion, and 2.027 billion yuan for 2025, 2026, and 2027, respectively, with corresponding PE ratios of 21, 18, and 15 times [5]